Search Results - "Kürti, Z"

Optimal line of hepatotomy for left lateral living donor liver transplantation (LDLT) according to the variations of left hepatic duct system by Kiss, M, Deshpande, R.R, Nguyen, T.T, Kürti, Z, Kovács, S, Pápai, Z, Németh, K, Szuák, A, Dudás, I, Kóbori, L, Nemeskéri, Ã

Get full text

P675 Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission in Crohn's disease and ulcerative colitis – 54 week data by Molnár, T., Farkas, K., Rutka, M., Ferenci, T., Nagy, F., Bálint, A., Bor, R., Milassin, A., Fábián, A., Végh, Z., Kürti, Z., Lakatos, P.L., Szepes, Z.

Get full text

P534 IBD-related malignancies observed in 2015–2018: 4 years’ results from the prospective nationwide Hungarian registry by Milassin, A, Rutka, M, Farkas, K, Bálint, A, Bor, R, Fábián, A, Szepes, Z, Szamosi, T, Szántó, K, Miheller, P, Barta, Z, Banai, J, Kovács, Á, Salamon, Á, Lakatos, L, Lakner, L, Palatka, K, Papp, M, Schafer, E, Novák, J, Erdélyi, Z, Kürti, Z, Lakatos, P L, Sarlós, P, Szigeti, N, Veres, G, Zaránd, A, Gelley, A, Vincze, Á, Nagy, F, Molnár, T

“…Abstract Background Inflammatory bowel diseases (IBD – Crohn’s disease (CD); ulcerative colitis (UC)) are associated with an increased risk of colorectal…”
Get full text

P829 The Burden of Colorectal Cancer in Patients with Ulcerative Colitis – Incidence and Risk factors from a Population-based Inception Cohort from Veszprem county, Western Hungary, from 1977–2020 by Wetwittayakhlang, P, Golovics, P, Gonczi, L, Khoury, A, Kurti, Z, Pandur, T, David, G, Erdelyi, Z, Szita, I, Lakatos, L, Lakatos, P L

“…Abstract Background Limited data are available on the incidence and risk of colorectal cancer (CRC) in ulcerative colitis (UC) from population-based studies in…”
Get full text

P570 The burden of anaemia remains significant over time in patients with inflammatory bowel disease at a tertiary referral centre by Singh Singh, K, Al-Khoury, A, Kurti, Z, Gonczi, L, Golovics, P, Kohen, R, Afif, W, Wild, G, Seidman, E, Bitton, A, Bessissow, T, Lakatos, P

“…Abstract Background Anaemia is an important complication and/or extra-intestinal manifestation of inflammatory bowel disease (IBD), as well as a predictor of…”
Get full text

P309 Impact of rapid access MR on clinical decision making and patient management in Crohn's disease in a tertiary referral center by Lovasz, B.D., Gonczi, L., Kurti, Z., Vegh, Z., Golovics, P.A., Rudas, G., Gecse, K.B., Lakatos, P.L.

Get full text

P145 Measuring access and quality of care indicators in inflammatory bowel disease in a tertiary referral center by Golovics, P.A., Gonczi, L., Kurti, Z., Lovasz, B.D., Gecse, K.B., Vegh, Z., Lakatos, P.L.

Get full text

P411 Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease centre: Accessibility, resource utilisation and outcomes by Restellini, S, Morin, I, Kurti, Z, Bessissow, T, Afif, W, Wild, G, Seidman, E, Bitton, A, Lakatos, P L

“…Abstract Background IBD impacts on patient’s physical health, social functioning and quality of life, contributing to the health-economic burden associated…”
Get full text

P409 Non-medical reverse switch between the originator infliximab and its biosimilar in patients with inflammatory bowel disease: clinical outcomes and therapeutic drug monitoring by Gonczi, L, Ilias, A, Szanto, K, Kurti, Z, Golovics, P A, Farkas, K, Schafer, E, Szepes, Z, Szalay, B, Vincze, A, Szamosi, T, Molnar, T, Lakatos, P

“…Abstract Background Switching from the originator to a biosimilar infliximab (IFX) in patients with inflammatory bowel disease (IBD) has proven to be…”
Get full text

P452 Impact of implementing a rapid access clinic in a high-volume inflammatory bowel disease centre: accessibility, resource utilisation and outcomes by Reinglas, J, Nene, S, Gonczi, L, Kurti, Z, Restellini, S, Kohen, R, Afif, W, Bessissow, T, Wild, G, Seidman, E, Bitton, A, Lakatos, P

“…Abstract Background Emergency situations in inflammatory bowel diseases (IBD) put significant burden on the patient and healthcare system as well. We aimed to…”
Get full text

P354 Perceived Quality of Care is associated to quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD centre by Gonczi, L, Kurti, Z, Verdon, C, Reinglas, J, Kohen, R, Morin, I, Chavez, K, Bessissow, T, Afif, W, Wild, G, Seidman, E, Bitton, A, Lakatos, P

“…Abstract Background Measuring the quality of care (QoC) in IBD has become increasingly important, yet complex assessment of quality indicators and perceived…”
Get full text

P150 High adherence to surveillance guidelines in IBD results in low CRC and dysplasia rates, while rates of dysplasia and cancer are low before the suggested start of surveillance. Results from a tertiary IBD centre by Singh, K, Al Khoury, A, Kurti, Z, Gonczi, L, Reinglas, J, Verdon, C, Kohen, R, Bessissow, T, Afif, W, Wild, G, Seidman, E, Bitton, A, Lakatos, P

“…Abstract Background Patients with Crohn’s disease(CD) and ulcerative colitis(UC) are at increased risk for colorectal dysplasia (CRD) and cancer (CRC)…”
Get full text

P633 Harmonisation of quality of care in an IBD centre impacts disease outcomes: importance of structure and process indicators by Reinglas, J, Restellini, S, Gonczi, L, Kurti, Z, Nene, S, Kohen, R, Afif, W, Bessissow, T, Wild, G, Seidman, E, Bitton, A, Lakatos, P

“…Abstract Background Optimal management of IBD requires harmonised monitoring and treatment pathways. We aimed to evaluate the quality of care at the McGill…”
Get full text

P623 Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database by Gonczi, L., Vegh, Z., Kurti, Z., Lovasz, B.D., Golovics, P.A., Fadgyas-Freyler, P., Gimesi-Orszagh, J., Gecse, K.B., Lakatos, P.L.

Get full text

P479 Quality of care and outcomes in a tertiary hospital inflammatory bowel disease (IBD) centre: Monitoring and treatment algorithms during follow-up by Kurti, Z, Restellini, S, Gonczi, L, Afif, W, Bessissow, T, Wild, G, Seidman, E, Kohen, R, Bitton, A, Lakatos, P L

“…Abstract Background Optimal management of IBD requires harmonised monitoring processes and treatment pathways. We aimed to retrospectively analyse quality of…”
Get full text

P694 Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomes by Ilias, A, Szanto, K, Gonczi, L, Kurti, Z, Golovics, P A, Schafer, E, Farkas, K, Szamosi, T, Szepes, Z, Molnar, T, Vincze, A, Lakatos, P L

“…Abstract Background The use of biosimilar infliximab (IFX) is effective and safe in inflammatory bowel disease (IBD). Switching from the originator to a…”
Get full text

P411 Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases by Kurti, Z., Rutka, M., Vegh, Z., Gonczi, L., Farkas, K., Lovasz, B.D., Gecse, K.B., Golovics, P.A., Szalay, B., Molnar, T., Lakatos, P.L.

Get full text

A76 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE. RESULTS FROM A TERTIARY IBD CENTER by Singh, K, Al Khoury, A, Kurti, Z, Gonczi, L, Reinglas, J, Verdon, C, Kohen, R, Bessissow, T, Afif, W, Wild, G, Seidman, E G, Bitton, A, Lakatos, P

“…Abstract Background Background: Patients with Crohn’s disease (CD) and ulcerative colitis (UC) are at increased risk for colorectal dysplasia (CRD) and cancer…”
Get full text

A78 IMPACT OF IMPLEMENTING A RAPID ACCESS CLINIC IN A HIGH-VOLUME INFLAMMATORY BOWEL DISEASE CENTER: ACCESSIBILITY, REASOURCE UTILISATION AND OUTCOMES by Nene, S, Reinglas, J, Gonczi, L, Kurti, Z, Restellini, S, Kohen, R, Afif, W, Bessissow, T, Wild, G, Seidman, E G, Bitton, A, Lakatos, P

“…Abstract Background Emergency situations in inflammatory bowel diseases (IBD) put significant burden on the patient and healthcare system as well. Aims We…”
Get full text

A112 HARMONIZATION OF QUALITY OF CARE IN AN IBD CENTER IMPACTS DISEASE OUTCOMES: IMPORTANCE OF STRUCTURE AND PROCESS INDICATORS by Reinglas, J, Restellini, S, Gonczi, L, Kurti, Z, Nene, S, Kohen, R, Afif, W, Bessissow, T, Wild, G, Seidman, E G, Lakatos, P

“…Abstract Background Optimal management of inflammatory bowel disease (IBD) requires harmonized monitoring strategy and treatment pathways. Comprehensive…”
Get full text